Increasing Colonoscopy Compliance Using a Blood-Based Risk Assessment Test for Colorectal Cancer

Chun Ren Lim, Mohamad Hasyim Mohd Sharil Sim, Eng Lok Seow, Prashanta Kumar Das, David Frederick Harris, Michelle Mei Lin Lee, Choong-Chin Liew, Robert Burakoff

Abstract


ColonSentry® is a minimally invasive, blood-based risk assessment test for colorectal cancer. The test is used to increase patient compliance with colonoscopy. Many physicians have inquired about the incidence of non-malignant lesions found in patients after colonoscopy prompted by an increased risk score on the ColonSentry test. Here we report on the colonoscopy results of five patients with increased ColonSentry risk scores. Of those five patients, three were determined to have polyps, one of which was pre-malignant.


Keywords


ColonSentry； Colorectal cancer； Biomarkers; Colonoscopy

Full Text:

PDF

References


[1] Hagga, F. A., & Boushey, R. P. (2009). Colorectal cancer epidemiology: Incidence, mortality, survival and risk factors. Clinics in Colon and Rectal Surgery, 22(4), 191- 197.

[2] American Cancer Society. (2011). Colorectal Cancer Facts & Figures 2011— 2013. Atlanta: American Cancer Society.

[3] American Society for Gastrointestinal Endoscopy. (2011). Complications of Colonoscopy. Gastrointestinal Endoscopy, 74, 745-752.

[4] Marshall, K.W., Mohr, S., Khettabi, F. E., Nossova, N., Chao, S., Bao, W.,…Liew, C. C. (2010). A blood-based biomarker panel for stratifying current risk for colorectal cancer. International Journal of Cancer, 126, 1177-1186.

[5] Yip, K.T., Das, P. K., Suria, D., Lim, C. R., Ng, G. H. & Liew, C. C. (2010) A case-controlled validation study of a blood-based seven-gene biomarker panel for colorectal cancer in Malaysia. Journal of Experimental & Clinical Cancer Research, 29, 128-134.




DOI: http://dx.doi.org/10.3968/gh.v1i1.5262

Refbacks

  • There are currently no refbacks.


Copyright (c)



Share us to:   

Reminder

We are currently accepting submissions via email only.

The registration and online submission functions have been disabled.

Please send your manuscripts to gh@cscanada.net，or   gh@cscanada.org for consideration.

We look forward to receiving your work.

 

 

 Articles published in Gastroenterology and Hepatology are licensed under Creative Commons Attribution 4.0 (CC-BY).

 GASTROENTEROLOGY AND HEPATOLOGY Editorial office

Address: 1055 Rue Lucien-L'Allier, Unit #772, Montreal, QC H3G 3C4, Canada.
Telephone: 1-514-558 6138 
Website: Http://www.cscanada.net Http://www.cscanada.org 
E-mail:gh@cscanada.net, gh@cscanada.org

Copyright © 2010 Canadian Research & Development Centre of Sciences and Cultures